home / stock / wint / wint news

WINT News and Press, Windtree Therapeutics Inc. From 11/08/23

Stock Information
Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com
Menu
WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...
WINT - Windtree to Present at the Sidoti Micro Cap Conference on November 16th

WARRINGTON, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, Preside...
WINT - Windtree to Present at the ThinkEquity Conference on October 19th in New York City

WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, Preside...

WINT - Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th

WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, Preside...

WINT - Bioline Rx, Clever Leaves among healthcare movers

2023-10-09 10:00:00 ET More on Health Care Select Sector SPDR Citi turns cautious on pharmaceuticals and biotech BofA Securities: Which small cap non-earner stocks to avoid For further details see: Bioline Rx, Clever Leaves among healthcare movers
WINT - Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th

WARRINGTON, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, Preside...

WINT - Windtree Therapeutics CEO Fraser buys 2.5K shares

2023-09-27 10:47:20 ET More on Windtree TherapeuticS Seeking Alpha’s Quant Rating on Windtree TherapeuticS Historical earnings data for Windtree TherapeuticS Financial information for Windtree TherapeuticS For further details see: Windtree Therapeu...

WINT - Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference

JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
WINT - 7 F-Rated Biotech Stocks You Shouldn't Touch With a 10-Foot Pole

2023-08-25 07:20:36 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product. But there are also plenty of pitfalls that make such...

WINT - Turkcell Iletisim Hizmetleri, Apellis Pharmaceuticals, Manchester United among premarket gainers' pack

2023-08-23 08:47:02 ET VCI Global ( VCIG ) +61% after announces visionary collaboration with Microsoft Azure OpenAI . iTeos Therapeutics ( ITOS ) +37% in reaction as Roche send anti-TIGIT developers higher after mistakenly-released cancer drug data . Arcus ...

WINT - Windtree Announces Issuance of Composition of Matter Patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office

WARRINGTON, Pa., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today reported that the United States Pate...
Previous 10 Next 10